Orchid is a biotechnology and healthcare startup founded in 2019, based in the United States. The company's mission, encapsulated in their slogan "We help couples have healthy babies," revolves around providing a new superpower to parents. This power comes in the form of safely and naturally mitigating genetic risks in their future child using Orchid's innovative solutions. The company recently secured a significant milestone, receiving a $12.00M Seed Round investment on 05 December 2023. The noteworthy investors participating in this round include Conviction Capital, Elad Gil, Pebblebed, Prometheus Fund, Anne Wojcicki, Mario Schlosser, Brian Armstrong, Starbloom Capital, Fidji Simo, Dylan Field. Orchid's commitment to revolutionizing prenatal care and genetics positions them as a promising venture for potential investors. For more information, interested parties can sign up at www.orchidhealth.com.
No recent news or press coverage available for Orchid.